申请人:Hisamitsu Pharmaceutical Co., Inc.
公开号:US04016166A1
公开(公告)日:1977-04-05
The compounds of the present invention can be represented by the following formula: ##STR1## wherein R is selected from the group consisting of hydrogen, lower alkyl, unsaturated lower alkyl, substituted lower alkyl and aralkyl; X is selected from the group consisting of O and S, possessing a high degree of pharmacological activities such as anti-inflammatory, analgetic, and central nervous system depressive activities, and certain of them are useful as new anti-inflammatory agents, analgesics and central nervous system depressants.
本发明的化合物可以用以下公式表示:##STR1## 其中R从氢、低烷基、不饱和低烷基、取代的低烷基和芳基等组成的群体中选择;X从O和S等组成的群体中选择,具有很高程度的药理活性,如抗炎、镇痛和中枢神经系统抑制活性,其中一些可作为新的抗炎药、镇痛剂和中枢神经系统抑制剂。